Emerging on the global stage at the 8th World Congress on Infectious Diseases held in Rome was Dr. Stephen Hsu, an esteemed professor from the Dental College of Georgia at Augusta University. He showcased his latest invention; a groundbreaking nanotechnology called Facilitated Self-Assembling Technology (FAST). The innovative technology could significantly transform sectors like drug development, viral infection prevention, and hospital hygiene.

In contrast to conventional nanotechnologies that require polymers, metals, surfactants, fat-based carriers, or complex engineering processes, FAST presents an alternative and simpler approach. It allows compounds, previously challenging to dissolve in water, to self-assemble into nanoparticles with minimal effort, thus enabling the formulation of stable, efficacious, and convenient drugs for both medical and consumer use.

Dr. Hsu particularly highlighted a green tea-derived compound, dubbed as EC16 or EGCG-palmitate, a lipid-soluble compound renowned for its antioxidant, anticancer, anti-inflammatory, and antimicrobial properties. While green tea’s benefits have long been acknowledged, applying it directly in clinical use has been hindered by stability concerns. However, FAST appears to overcome these challenges and revolutionizes the transformation of EC16 and similar hydrophobic compounds into water-friendly nanoparticles.

Dr. Hsu’s life work is a fascinating combination of lifelong dedication to research and a soul-touching personal backstory. Having endured illness as a young boy in a labor camp in China, he credits green tea for his survival. His ultimate goal now is to convert the natural advantages of green tea into world-changing therapies and thereby extend its benefits to a broader global audience.